ACTRN12617001122347Not yet recruitingPhase 4
The Effect of vaginal Bromocriptine in controlling Adenomyosis symptoms
ahed ezzat allam0 sites68 target enrollmentStarted: July 31, 2017Last updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 68
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 23 Years to 49 Years (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
A Randomised Controlle Study of Vaginal Bromocriptine and Oral Carbegoline in treating Hyperprolacrinemia among women Attending Infertility Clinic in AbuthFertility-femalePACTR202105785593643Irshad Asma60
Recruiting
Phase 2
Role of bromocriptine through enteral route for decreasing neurogenic fever in severe head Injury patients in Trauma Intensive Care Unit.CTRI/2023/08/056344Institute of medical sciences Banaras hindu university
Not yet recruiting
Not Applicable
Investigation of tolerablity & effectiveness of Bromocriptine in comparison with Teneligliptin in patients diagnosed with type II diabetes mellitusCTRI/2018/05/013591asrin Nisha
Completed
Phase 2
effects of Bromocriptine and Metformin on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovarian syndromeIRCT201512313461N7?Vice chancellor for research, Kermanshah University of Medical Sciences64
Active, not recruiting
Not Applicable
Überwachung einer Therapie mit Bromocriptin bei Patienten mit klinisch relevanter Risperidon-induzierter Hyperprolaktinämie. Eine psychiatrisch-endokrinologische Ver-laufsbeobachtung.Schizophrene Patienten mit einer Risperidon induzierten HyperprolaktinämieEUCTR2005-006037-33-DEniversitätsklinikum Bonn; Klinik und Poliklinik für Psychiatrie und Psychotherapie